CARPENTER, Randall L.,ROBERTS, Kathryn,BEAR, Mark F.
申请号：
LT07862184
公开号：
LT2083811T
申请日:
2007.11.21
申请国别(地区):
LT
年份:
2017
代理人:
摘要：
Subjects having at least one condition selected from the group consisting of mental retardation, Down's syndrome, fragile X syndrome and autism are treated with a composition that includes gamma-am inobutyric acid agonists and/or MI muscarinic receptor antagonists. The gamma-am inobutyric acid agonist (GABA) can be a GABA(B) agonist, such as baclofen. GABA(B) agonists can be used in combination with Group I mGluR antagonists and MI muscarinic receptor antagonists in methods of treating humans.
